Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$78.71 - $87.02 $56,671 - $62,654
720 Added 11.02%
7,252 $571,000
Q1 2024

Apr 02, 2024

BUY
$82.84 - $88.09 $541,110 - $575,403
6,532 New
6,532 $569,000
Q3 2023

Oct 10, 2023

SELL
$78.22 - $90.4 $68,051 - $78,648
-870 Reduced 10.7%
7,263 $569,000
Q3 2022

Oct 03, 2022

SELL
$80.75 - $95.31 $177,246 - $209,205
-2,195 Reduced 21.25%
8,133 $657,000
Q4 2021

Jan 11, 2022

SELL
$99.53 - $127.75 $45,584 - $58,509
-458 Reduced 4.25%
10,328 $1.07 Million
Q2 2021

Jul 07, 2021

SELL
$118.19 - $131.5 $532,209 - $592,144
-4,503 Reduced 29.45%
10,786 $1.34 Million
Q1 2021

May 03, 2021

SELL
$111.18 - $119.74 $95,392 - $102,736
-858 Reduced 5.31%
15,289 $1.81 Million
Q4 2020

Feb 18, 2021

SELL
$100.57 - $117.14 $238,753 - $278,090
-2,374 Reduced 12.82%
16,147 $1.89 Million
Q3 2020

Nov 03, 2020

BUY
$90.13 - $108.78 $417,211 - $503,542
4,629 Added 33.32%
18,521 $1.93 Million
Q2 2020

Jul 20, 2020

BUY
$84.11 - $103.33 $159,893 - $196,430
1,901 Added 15.85%
13,892 $1.27 Million
Q1 2020

May 15, 2020

BUY
$72.92 - $121.3 $328,942 - $547,184
4,511 Added 60.31%
11,991 $1.08 Million
Q4 2019

Feb 12, 2020

SELL
$104.49 - $114.54 $175,229 - $192,083
-1,677 Reduced 18.31%
7,480 $849,000
Q3 2019

Nov 04, 2019

SELL
$98.02 - $111.18 $53,911 - $61,149
-550 Reduced 5.67%
9,157 $995,000
Q2 2019

Aug 07, 2019

SELL
$84.15 - $99.38 $567,591 - $670,318
-6,745 Reduced 41.0%
9,707 $945,000
Q1 2019

May 13, 2019

BUY
$82.45 - $93.79 $118,975 - $135,338
1,443 Added 9.61%
16,452 $1.5 Million
Q4 2018

May 22, 2019

BUY
$85.8 - $99.49 $1.29 Million - $1.49 Million
15,009 New
15,009 $1.37 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Symmetry Partners, LLC Portfolio

Follow Symmetry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.